| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accuracy of Linking VR-12 and PROMIS Global Health Scores in Clinical Practice
|
Lapin, Brittany R.
|
|
2018
|
|
10 |
p. 1226-1233
|
artikel
|
| 2 |
A Comparison of National Guidelines for Network Meta-Analysis
|
Laws, Andrew
|
|
|
|
10 |
p. 1178-1186
|
artikel
|
| 3 |
A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist–Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH)
|
Tam-Tham, Helen
|
|
|
|
10 |
p. 1128-1136
|
artikel
|
| 4 |
Adaptive Health Technology Assessment: A Scoping Review of Methods
|
Nemzoff, Cassandra
|
|
|
|
10 |
p. 1549-1557
|
artikel
|
| 5 |
A Decade of Health Innovation: The Impact of New Medicines on Patient Health and the Implications for NICE’s Size of Benefit Multiplier
|
Shafrin, Jason
|
|
|
|
10 |
p. 1435-1439
|
artikel
|
| 6 |
A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data
|
Wang, Han-I
|
|
2018
|
|
10 |
p. 1176-1185
|
artikel
|
| 7 |
A (Latent) Class of Their Own: Response Patterns in Trading Off Quantity and Quality of Life in Time Trade-Off Exercises
|
van Nooten, F.E.
|
|
2017
|
|
10 |
p. 1403-1410
|
artikel
|
| 8 |
An Exploratory Study on Using Principal-Component Analysis and Confirmatory Factor Analysis to Identify Bolt-On Dimensions: The EQ-5D Case Study
|
Finch, Aureliano Paolo
|
|
2017
|
|
10 |
p. 1362-1375
|
artikel
|
| 9 |
A Qualitative Investigation to Develop an Adapted Version of the EQ-5D-Y-3L for Use in Children Aged 2-4 Years
|
Dalziel, Kim
|
|
|
|
10 |
p. 1525-1534
|
artikel
|
| 10 |
A Real-World Evidence Analysis of Associations Among Costs, Quality of Life, and Disease-Severity Indicators of Alzheimer’s Disease in Thailand
|
Kongpakwattana, Khachen
|
|
|
|
10 |
p. 1137-1145
|
artikel
|
| 11 |
Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance Tests
|
Tervonen, Tommi
|
|
2018
|
|
10 |
p. 1192-1197
|
artikel
|
| 12 |
Assessment of Patient-Reported Outcomes in Industry-Sponsored Phase I Oncology Studies: Considerations for Translating Theory Into Practice
|
Gnanasakthy, Ari
|
|
|
|
10 |
p. 1440-1443
|
artikel
|
| 13 |
Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis
|
Hohmann, Natalie
|
|
2018
|
|
10 |
p. 1186-1191
|
artikel
|
| 14 |
A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain
|
Gloria, Mac Ardy Junio
|
|
|
|
10 |
p. 1423-1434
|
artikel
|
| 15 |
A Systematic Review of International Guidance for Self-Report and Proxy Completion of Child-Specific Utility Instruments
|
Mpundu-Kaambwa, Christine
|
|
|
|
10 |
p. 1791-1804
|
artikel
|
| 16 |
Author Reply
|
Kim, David D.
|
|
|
|
10 |
p. 1578-1579
|
artikel
|
| 17 |
Author Response: Patient Engagement
|
Frank, Lori
|
|
2017
|
|
10 |
p. 1433
|
artikel
|
| 18 |
A Value Framework to Assess Patient-Facing Digital Health Technologies That Aim to Improve Chronic Disease Management: A Delphi Approach
|
Haig, Madeleine
|
|
|
|
10 |
p. 1474-1484
|
artikel
|
| 19 |
A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management
|
Kunst, Natalia R.
|
|
|
|
10 |
p. 1102-1110
|
artikel
|
| 20 |
Basal Insulin Regimens for Adults with Type 1 Diabetes Mellitus: A Cost-Utility Analysis
|
Dawoud, Dalia
|
|
2017
|
|
10 |
p. 1279-1287
|
artikel
|
| 21 |
Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools
|
Cerisoli, Francesco
|
|
|
|
10 |
p. 1760-1767
|
artikel
|
| 22 |
Choosing Video Instead of In-Clinic Consultations in Primary Care in Israel: Discrete Choice Experiment Among Key Stakeholders—Patients, Primary Care Physicians, and Policy Makers
|
Chudner, Irit
|
|
|
|
10 |
p. 1187-1196
|
artikel
|
| 23 |
Common Patient-Reported Outcomes Within the Food and Drug Administration Voice of the Patient Reports
|
Metz, Cameron
|
|
|
|
10 |
p. 1743-1751
|
artikel
|
| 24 |
Comparing Methods for Estimating Direct Costs of Adverse Drug Events
|
Gyllensten, Hanna
|
|
2017
|
|
10 |
p. 1299-1310
|
artikel
|
| 25 |
Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis
|
Tervonen, Tommi
|
|
2017
|
|
10 |
p. 1394-1402
|
artikel
|
| 26 |
Comparison of Timed Automata with Discrete Event Simulation for Modeling of Biomarker-Based Treatment Decisions: An Illustration for Metastatic Castration-Resistant Prostate Cancer
|
Degeling, Koen
|
|
2017
|
|
10 |
p. 1411-1419
|
artikel
|
| 27 |
Comparisons of Medical Cost Trajectories Between Non-Hispanic Black and Non-Hispanic White Patients With Newly Diagnosed Localized Prostate Cancer
|
Liu, Yu
|
|
|
|
10 |
p. 1444-1452
|
artikel
|
| 28 |
Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration
|
Kunst, Natalia
|
|
|
|
10 |
p. 1461-1473
|
artikel
|
| 29 |
Copyright/Subscription
|
|
|
|
|
10 |
p. v
|
artikel
|
| 30 |
Copyright/Subscription
|
|
|
2018
|
|
10 |
p. A3
|
artikel
|
| 31 |
Copyright/Subscription
|
|
|
2017
|
|
10 |
p. iv
|
artikel
|
| 32 |
Copyright/Subscription
|
|
|
|
|
10 |
p. iv
|
artikel
|
| 33 |
Copyright/Subscription
|
|
|
|
|
10 |
p. v
|
artikel
|
| 34 |
Copyright/Subscription
|
|
|
|
|
10 |
p. iv
|
artikel
|
| 35 |
Copyright/Subscription
|
|
|
|
|
10 |
p. v
|
artikel
|
| 36 |
Cost-Effectiveness Analysis of a Mobile Mammography Unit for Breast Cancer Screening to Reduce Geographic and Social Health Inequalities
|
De Mil, Rémy
|
|
|
|
10 |
p. 1111-1118
|
artikel
|
| 37 |
Cost-Effectiveness Analysis of Branded Drugs With Market Demand and Insurance
|
Pauly, Mark V.
|
|
|
|
10 |
p. 1476-1483
|
artikel
|
| 38 |
Cost-Effectiveness and Economic Burden Analyses on All First-Line Treatments of Chronic Lymphocytic Leukemia
|
Alrawashdh, Neda
|
|
|
|
10 |
p. 1685-1695
|
artikel
|
| 39 |
Cost-Effectiveness of a Serum Biomarker Test for Risk-Stratified Liver Ultrasound Screening for Hepatocellular Carcinoma
|
Carter, Hannah E.
|
|
|
|
10 |
p. 1454-1462
|
artikel
|
| 40 |
Cost Effectiveness of Candida Polymerase Chain Reaction Detection and Empirical Antifungal Treatment among Patients with Suspected Fungal Peritonitis in the Intensive Care Unit
|
Pagès, Arnaud
|
|
2017
|
|
10 |
p. 1319-1328
|
artikel
|
| 41 |
Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia
|
Nguyen, Joehl T.
|
|
|
|
10 |
p. 1292-1299
|
artikel
|
| 42 |
Cost-Effectiveness of Ivacaftor Therapy for Treatment of Cystic Fibrosis Patients With the G551D Gating Mutation
|
Wherry, Kael
|
|
|
|
10 |
p. 1332-1339
|
artikel
|
| 43 |
Cost-Effectiveness of Medicinal Cannabis for Management of Refractory Symptoms Associated With Chronic Conditions: A Systematic Review of Economic Evaluations
|
Erku, Daniel
|
|
|
|
10 |
p. 1520-1530
|
artikel
|
| 44 |
Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands
|
Velikanova, Rimma
|
|
|
|
10 |
p. 1696-1704
|
artikel
|
| 45 |
Cost-Effectiveness of Sacubitril/Valsartan in Germany: An Application of the Efficiency Frontier
|
van der Pol, Simon
|
|
|
|
10 |
p. 1119-1127
|
artikel
|
| 46 |
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines
|
Ramos, Isaac Corro
|
|
2017
|
|
10 |
p. 1260-1269
|
artikel
|
| 47 |
Cost of Human Immunodeficiency Virus (HIV) and Determinants of Healthcare Costs in HIV-Infected Treatment-Naive Patients Initiated on Antiretroviral Therapy in Germany: Experiences of the PROPHET Study
|
Valbert, Frederik
|
|
|
|
10 |
p. 1324-1331
|
artikel
|
| 48 |
Costs of Early Invasive Breast Cancer in England Using National Patient-Level Data
|
Sun, Li
|
|
|
|
10 |
p. 1316-1323
|
artikel
|
| 49 |
Deriving a Preference-Based Measure for People With Duchenne Muscular Dystrophy From the DMD-QoL
|
Rowen, Donna
|
|
|
|
10 |
p. 1499-1510
|
artikel
|
| 50 |
Development and Psychometric Testing of the Caregiver Self-Efficacy in Contributing to Patient Self-Care Scale
|
De Maria, Maddalena
|
|
|
|
10 |
p. 1407-1415
|
artikel
|
| 51 |
Development and Validation of the AFImpact: An Atrial Fibrillation–Specific Measure of Patient-Reported Health-Related Quality of Life
|
Coyne, Karin S.
|
|
2017
|
|
10 |
p. 1355-1361
|
artikel
|
| 52 |
Development of a Patient-Reported Outcome Measure for Geriatric Care: The Older Persons and Informal Caregivers Survey Short Form
|
Santoso, Angelina M.M.
|
|
2018
|
|
10 |
p. 1198-1204
|
artikel
|
| 53 |
Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China
|
Xie, Shitong
|
|
|
|
10 |
p. 1391-1399
|
artikel
|
| 54 |
Does Scoring Method Impact Estimation of Significant Individual Changes Assessed by Patient-Reported Outcome Measures? Comparing Classical Test Theory Versus Item Response Theory
|
Tang, Xiaodan
|
|
|
|
10 |
p. 1518-1524
|
artikel
|
| 55 |
Does Selecting Covariates Using Factor Analysis in Mapping Algorithms Improve Predictive Accuracy? A Case of Predicting EQ-5D-5L and SF-6D Utilities from the Women’s Health Questionnaire
|
Kaambwa, Billingsley
|
|
2018
|
|
10 |
p. 1205-1217
|
artikel
|
| 56 |
Economic Analysis of Vaccination Programs: An ISPOR Good Practices for Outcomes Research Task Force Report
|
Mauskopf, Josephine
|
|
2018
|
|
10 |
p. 1133-1149
|
artikel
|
| 57 |
Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
|
Dakin, Helen A.
|
|
|
|
10 |
p. 1340-1348
|
artikel
|
| 58 |
Economic Evaluations of Guideline-Directed Medical Therapies for Heart Failure With Reduced Ejection Fraction: A Systematic Review
|
Kuan, Wai-Chee
|
|
|
|
10 |
p. 1558-1576
|
artikel
|
| 59 |
Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice
|
Fens, Tanja
|
|
|
|
10 |
p. 1092-1101
|
artikel
|
| 60 |
Editorial Board
|
|
|
|
|
10 |
p. vi
|
artikel
|
| 61 |
Editorial Board
|
|
|
2018
|
|
10 |
p. IFC
|
artikel
|
| 62 |
Editorial Board
|
|
|
2017
|
|
10 |
p. IFC
|
artikel
|
| 63 |
Editorial Board
|
|
|
|
|
10 |
p. v
|
artikel
|
| 64 |
Editorial Board
|
|
|
|
|
10 |
p. vi
|
artikel
|
| 65 |
Editorial Board
|
|
|
|
|
10 |
p. v
|
artikel
|
| 66 |
Editorial Board
|
|
|
|
|
10 |
p. vi
|
artikel
|
| 67 |
Effect of Dipeptidyl Peptidase-4 Inhibitors on Heart Failure: A Network Meta-Analysis
|
Guo, Wen-Qin
|
|
2017
|
|
10 |
p. 1427-1430
|
artikel
|
| 68 |
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients with Ankylosing Spondylitis: 28-Week Results of the GO-ALIVE Trial
|
Reveille, John D.
|
|
|
|
10 |
p. 1281-1285
|
artikel
|
| 69 |
Effects of Intravenous Golimumab on Health-Related Quality of Life in Patients With Psoriatic Arthritis: 24-Week Results of the GO-VIBRANT Trial
|
Husni, M. Elaine
|
|
|
|
10 |
p. 1286-1291
|
artikel
|
| 70 |
Effects of Transitioning to Medicare Part D on Access to Drugs for Medical Conditions among Dual Enrollees with Cancer
|
Adams, Alyce S.
|
|
2017
|
|
10 |
p. 1345-1354
|
artikel
|
| 71 |
Encouraging Mammograms Using Behavioral Economics: A Randomized Controlled Trial in Chile
|
Duarte, Fabián
|
|
|
|
10 |
p. 1463-1469
|
artikel
|
| 72 |
Estimating a Dutch Value Set for the Pediatric Preference-Based CHU9D Using a Discrete Choice Experiment with Duration
|
Rowen, Donna
|
|
2018
|
|
10 |
p. 1234-1242
|
artikel
|
| 73 |
Estimating Quality of Life Decrements in Oncology Using Time to Death
|
Versteegh, Matthijs
|
|
|
|
10 |
p. 1673-1677
|
artikel
|
| 74 |
Estimating the Theoretical Cost Implications of Funding New Drugs Considered Not to Be Cost-Effective
|
Kennedy, Cormac
|
|
|
|
10 |
p. 1402-1406
|
artikel
|
| 75 |
Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, and Geography for Equity-Informative Cost-Effectiveness Analysis
|
Kowal, Stacey
|
|
|
|
10 |
p. 1485-1493
|
artikel
|
| 76 |
Estimation of the Width of Uncertainty in Care Consumption and Costs When Using Common Data Collection Tools in Economic Evaluations: A Benchmark for Sensitivity Analyses
|
Daval, Laure
|
|
|
|
10 |
p. 1416-1422
|
artikel
|
| 77 |
Estimators Used in Multisite Healthcare Costing Studies in Low- and Middle-Income Countries: A Systematic Review and Simulation Study
|
Clarke-Deelder, Emma
|
|
|
|
10 |
p. 1146-1153
|
artikel
|
| 78 |
Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program Decisions: Incremental Cost-Effectiveness Ratio Thresholds and Decision-Modifying Factors
|
Chen, Gengshi
|
|
|
|
10 |
p. 1300-1306
|
artikel
|
| 79 |
Extending Beyond Bagust and Beale: Fully Parametric Piecewise Exponential Models for Extrapolation of Survival Outcomes in Health Technology Assessment
|
Cooney, Philip
|
|
|
|
10 |
p. 1510-1517
|
artikel
|
| 80 |
External Validation of a Colorectal Cancer Model Against Screening Trial Long-Term Follow-Up Data
|
Thomas, Chloe
|
|
|
|
10 |
p. 1154-1161
|
artikel
|
| 81 |
Focused Ultrasound Thalamotomy and Other Interventions for Medication-Refractory Essential Tremor: An Indirect Comparison of Short-Term Impact on Health-Related Quality of Life
|
Langford, Bryony E.
|
|
2018
|
|
10 |
p. 1168-1175
|
artikel
|
| 82 |
Forecasting the Long-Term Clinical and Economic Outcomes of Lumacaftor/Ivacaftor in Cystic Fibrosis Patients with Homozygous phe508del Mutation
|
Dilokthornsakul, Piyameth
|
|
2017
|
|
10 |
p. 1329-1335
|
artikel
|
| 83 |
French Patients with Hepatitis C Treated with Direct-Acting Antiviral Combinations: The Effect on Patient-Reported Outcomes
|
Cacoub, Patrice
|
|
2018
|
|
10 |
p. 1218-1225
|
artikel
|
| 84 |
Frequently Used Patient-Reported Outcome Measures of General Physical Function Were Highly Correlated With a Multitask Performance Outcome Test Battery
|
Liegl, Gregor
|
|
|
|
10 |
p. 1752-1759
|
artikel
|
| 85 |
Good Days and Bad Days: Measuring Health-Related Quality of Life in People With Epilepsy
|
Wester, Valérie
|
|
|
|
10 |
p. 1470-1475
|
artikel
|
| 86 |
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force
|
Wang, Shirley V.
|
|
|
|
10 |
p. 1663-1672
|
artikel
|
| 87 |
Health-Related Quality of Life in Neurological Disorders Most Commonly Associated With Zika-Virus Infection: A Systematic Review
|
|
|
|
|
10 |
p. 1402
|
artikel
|
| 88 |
How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China
|
Zhang, Mengqian
|
|
|
|
10 |
p. 1768-1777
|
artikel
|
| 89 |
How Good Is Machine Learning in Predicting All-Cause 30-Day Hospital Readmission? Evidence From Administrative Data
|
Li, Qing
|
|
|
|
10 |
p. 1307-1315
|
artikel
|
| 90 |
How Much Is a Human Life Worth? A Systematic Review
|
Keller, Elena
|
|
|
|
10 |
p. 1531-1541
|
artikel
|
| 91 |
How to Prevent Vaccines Falling Victim to Their Own Success: Intertemporal Dependency of Incidence Levels on Indirect Effects in Economic Reevaluations
|
Sandmann, Frank
|
|
|
|
10 |
p. 1391-1399
|
artikel
|
| 92 |
Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review
|
van Egdom, Laurentine S.E.
|
|
|
|
10 |
p. 1197-1226
|
artikel
|
| 93 |
Inclusion of Carer Health-Related Quality of Life in National Institute for Health and Care Excellence Appraisals
|
Pennington, Becky M.
|
|
|
|
10 |
p. 1349-1357
|
artikel
|
| 94 |
Incremental Costs and Cost Effectiveness of Intensive Treatment in Individuals with Type 2 Diabetes Detected by Screening in the ADDITION-UK Trial: An Update with Empirical Trial–Based Cost Data
|
Laxy, Michael
|
|
2017
|
|
10 |
p. 1288-1298
|
artikel
|
| 95 |
Is Multicriteria Decision Analysis a Resource Allocation Framework?
|
Dionne, François
|
|
|
|
10 |
p. 1400-1401
|
artikel
|
| 96 |
ISPOR Code of Ethics 2017 (4th Edition)
|
Santos, Jessica
|
|
2017
|
|
10 |
p. 1227-1242
|
artikel
|
| 97 |
Letter to the Editor: Emerging Guidelines for Patient Engagement in Research
|
Boutin, Marc
|
|
2017
|
|
10 |
p. 1431-1432
|
artikel
|
| 98 |
Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature
|
Drolet, Mélanie
|
|
2018
|
|
10 |
p. 1250-1258
|
artikel
|
| 99 |
Modeling Early Warning Systems: Construction and Validation of a Discrete Event Simulation Model for Heart Failure
|
Albuquerque de Almeida, Fernando
|
|
|
|
10 |
p. 1435-1445
|
artikel
|
| 100 |
Moving Beyond Quality-Adjusted Life-Years in Elderly Care: How Can Multicriteria Decision Analysis Complement Cost-Effectiveness Analysis in Local-Level Decision Making
|
Hoedemakers, Maaike
|
|
|
|
10 |
p. 1717-1725
|
artikel
|
| 101 |
Nephrectomy Complication Is a Risk Factor of Clinically Meaningful Decrease in Health Utility among Living Kidney Donors
|
Hosseini, Kossar
|
|
2017
|
|
10 |
p. 1376-1382
|
artikel
|
| 102 |
Next Edition of the ISPOR Code of Ethics: Is It Setting Us up for the Era of Digitized Health Care?
|
|
|
2017
|
|
10 |
p. 1243-1244
|
artikel
|
| 103 |
[No title]
|
Palumbo, Francis B.
|
|
|
|
10 |
p. 1400-1401
|
artikel
|
| 104 |
On the Optimization of Bayesian D-Efficient Discrete Choice Experiment Designs for the Estimation of QALY Tariffs That Are Corrected for Nonlinear Time Preferences
|
Jonker, Marcel F.
|
|
|
|
10 |
p. 1162-1169
|
artikel
|
| 105 |
Patient Preferences for Device-Aided Treatments Indicated for Advanced Parkinson Disease
|
Marshall, Thomas
|
|
2017
|
|
10 |
p. 1383-1393
|
artikel
|
| 106 |
Patient Preferences in Surveillance: Findings From a Discrete Choice Experiment in the “My Follow-Up” Study
|
McFerran, Ethna
|
|
|
|
10 |
p. 1373-1383
|
artikel
|
| 107 |
PCSK9 Inhibitors Show Value for Patients and the US Health Care System
|
Cheng, Wei-Han
|
|
2017
|
|
10 |
p. 1270-1278
|
artikel
|
| 108 |
Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials
|
King-Kallimanis, Bellinda L.
|
|
|
|
10 |
p. 1543-1548
|
artikel
|
| 109 |
Postacute Expenditures Among Patients Discharged Home After Stroke or Transient Ischemic Attack: The COMprehensive Post-Acute Stroke Services (COMPASS) Trial
|
Hou, Yucheng
|
|
|
|
10 |
p. 1453-1460
|
artikel
|
| 110 |
Prevalence and Risk Factors of Primary Dysmenorrhea in Students: A Meta-Analysis
|
Wang, Liwen
|
|
|
|
10 |
p. 1678-1684
|
artikel
|
| 111 |
Psychometric Properties of EQ-5D-5L Scoring Algorithms for the United Kingdom in Metastatic Merkel Cell Carcinoma
|
Bharmal, Murtuza
|
|
|
|
10 |
p. 1170-1177
|
artikel
|
| 112 |
Quantifying Value of Hope
|
Reed, Shelby D.
|
|
|
|
10 |
p. 1511-1519
|
artikel
|
| 113 |
Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular Dystrophy
|
Landfeldt, Erik
|
|
|
|
10 |
p. 1490-1498
|
artikel
|
| 114 |
Recognizing the Broader Value of Meningococcal Vaccination: A Matter of Evidence, Ability, or Willingness?
|
Neri, Margherita
|
|
|
|
10 |
p. 1535-1542
|
artikel
|
| 115 |
Reporting Answer Categorization and Scoring Methods in the Criteria for Health Economic Quality Evaluation (CHEQUE) Tool
|
Nian, Tao
|
|
|
|
10 |
p. 1577-1578
|
artikel
|
| 116 |
Researchers, Patients, and Stakeholders Evaluating Comparative-Effectiveness Research: A Mixed-Methods Study of the PCORI Reviewer Experience
|
Forsythe, Laura P.
|
|
2018
|
|
10 |
p. 1161-1167
|
artikel
|
| 117 |
Reviewer Acknowledgement 20/10
|
|
|
2017
|
|
10 |
p. 1434-1439
|
artikel
|
| 118 |
Risk of Dependency: A Challenge for Health and Social Care Planning—Observational Stroke Cohort
|
Queralt-Tomas, Luisa
|
|
|
|
10 |
p. 1083-1091
|
artikel
|
| 119 |
Scientific Evidence in Health Technology Assessment Reports: An In-Depth Analysis of European Assessments on High-Risk Medical Devices
|
Olberg, Britta
|
|
2017
|
|
10 |
p. 1420-1426
|
artikel
|
| 120 |
Social Impact of Prophylactic Migraine Treatments in Germany: A State-Transition and Open Cohort Approach
|
Seddik, Ahmed H.
|
|
|
|
10 |
p. 1446-1453
|
artikel
|
| 121 |
State Laws and Generic Substitution in the Year After New Generic Competition
|
Rome, Benjamin N.
|
|
|
|
10 |
p. 1736-1742
|
artikel
|
| 122 |
Strengthening the Interface of Evidence-Based Decision Making Across European Regulators and Health Technology Assessment Bodies
|
Jansen, Ella
|
|
|
|
10 |
p. 1726-1735
|
artikel
|
| 123 |
Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis
|
Bhattacharyya, Subrata
|
|
|
|
10 |
p. 1705-1716
|
artikel
|
| 124 |
Systematic Review and Network Meta-Analysis of Treatments for Chemotherapy-Naive Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer
|
McCool, Rachael
|
|
2018
|
|
10 |
p. 1259-1268
|
artikel
|
| 125 |
Table of Contents
|
|
|
|
|
10 |
p. i-iv
|
artikel
|
| 126 |
Table of Contents
|
|
|
2018
|
|
10 |
p. A1-A2
|
artikel
|
| 127 |
Table of Contents
|
|
|
2017
|
|
10 |
p. i-iii
|
artikel
|
| 128 |
Table of Contents
|
|
|
|
|
10 |
p. i-iii
|
artikel
|
| 129 |
Table of Contents
|
|
|
|
|
10 |
p. i-iv
|
artikel
|
| 130 |
Table of Contents
|
|
|
|
|
10 |
p. i-iii
|
artikel
|
| 131 |
Table of Contents
|
|
|
|
|
10 |
p. i-iv
|
artikel
|
| 132 |
Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments
|
Purba, Fredrick Dermawan
|
|
2018
|
|
10 |
p. 1243-1249
|
artikel
|
| 133 |
The Evolving Nature of Health Technology Assessment: A Critical Appraisal of NICE’s New Methods Manual
|
Angelis, Aris
|
|
|
|
10 |
p. 1503-1509
|
artikel
|
| 134 |
The Integration of Value Assessment and Social Network Methods for Breast Health Navigation Among African Americans
|
Molina, Yamilé
|
|
|
|
10 |
p. 1494-1502
|
artikel
|
| 135 |
The Role of Noncomparative Evidence in Health Technology Assessment Decisions
|
Griffiths, Elizabeth A.
|
|
2017
|
|
10 |
p. 1245-1251
|
artikel
|
| 136 |
The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study
|
Brekke, Lee
|
|
2017
|
|
10 |
p. 1252-1259
|
artikel
|
| 137 |
Toward Better Data Dashboards for US Drug Value Assessments
|
Neumann, Peter J.
|
|
|
|
10 |
p. 1484-1489
|
artikel
|
| 138 |
Trade-Offs in Quality-of-Life Assessment Between the Modified Rankin Scale and Neuro-QoL Measures
|
Askew, Robert L.
|
|
|
|
10 |
p. 1366-1372
|
artikel
|
| 139 |
Unique Review Criteria and Patient and Stakeholder Reviewers: Analysis of PCORI’s Approach to Research Funding
|
Forsythe, Laura P.
|
|
2018
|
|
10 |
p. 1152-1160
|
artikel
|
| 140 |
Use of Real-World Evidence to Support FDA Approval of Oncology Drugs
|
Feinberg, Bruce A.
|
|
|
|
10 |
p. 1358-1365
|
artikel
|
| 141 |
Vaccination Programs: Economic and Leadership Considerations
|
Hartigan-Go, Kenneth Y.
|
|
2018
|
|
10 |
p. 1150-1151
|
artikel
|
| 142 |
Value of Implementation of Strategies to Increase the Adherence of Health Professionals and Cancer Survivors to Guideline-Based Physical Exercise
|
Mewes, Janne C.
|
|
2017
|
|
10 |
p. 1336-1344
|
artikel
|
| 143 |
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial
|
Hall, Peter S.
|
|
2017
|
|
10 |
p. 1311-1318
|
artikel
|
| 144 |
Value of Nonpharmacological Interventions for People With an Acquired Brain Injury: A Systematic Review of Economic Evaluations
|
Mitchell, Eileen
|
|
|
|
10 |
p. 1778-1790
|
artikel
|
| 145 |
Willingness to Pay for Health Improvements Using Stated Preferences: Prevention Versus Treatment
|
Wolff, Ellen
|
|
|
|
10 |
p. 1384-1390
|
artikel
|
Tijdschrift beschrijving